Improved adjuvant therapy of G250-expressing tumors

Details for Australian Patent Application No. 2005259481 (hide)

Owner Wilex AG

Inventors Warnaar, Sven; Wilhelm, Olaf

Agent Davies Collison Cave

Pub. Number AU-B-2005259481

PCT Pub. Number WO2006/002889

Priority 60/584,679 02.07.04 US

Filing date 29 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 22 April 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002889 Priority application(s): WO2006/002889

22 April 2010 Application Accepted

  Published as AU-B-2005259481

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259487-Conjugates of antibody and duoarmycin derivatives as antitumor agents

2005259478-Oral dosage form safeguarded against abuse containing (1R, 2R)-3-(3-dimethylamino-1-ethyl-2-meth yl-propyl)-phenol